3 completed, 2 recruiting, 2 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow DAT protocol 1: new trials by email Literature Review of DAT protocol 1 trials Research Report on DAT protocol 1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia. TAD® 600 mg/4 mL powder and solvent for solution for injection, Saline solution 0.9% of sodium chloride - Pneumonia, Myocardial Injury | Phase 3 | Unknown | Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica | 178 | 2024-06-25 | 2024-11-27 |
| TAD in Primary Breast Cancer With Initially ≥ 3 Suspicious Lymph Nodes Targeted axilllary dissection (TAD) followed by axillary lymph node dissection (ALND) - Breast Cancer, Node-positive Breast Cancer | Recruiting | Kliniken Essen-Mitte | 150 | 2022-03-07 | 2023-02-15 | |
| Targeted Axillary Dissection After Neo-adjuvant Chemotherapy TAD (Targeted Axillary Dissection) - Breast Cancer | Unknown | Universitair Ziekenhuis Brussel | 100 | 2021-04-21 | 2023-11-07 | |
| ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy Targeted axillary dissection (TAD) by ICG, Targeted axillary dissection (TAD) by Blue patent - Breast Cancer, Axillary Metastases | Recruiting | Hospital Universitari de Bellvitge | 43 | 2021-01-01 | 2026-09-17 | |
| Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD) Not suitable for TAD, Suitable for TAD - Early Stage Breast Cancer | Completed | Kliniken Essen-Mitte | 548 | 2017-02-01 | 2021-02-03 | |
| Sentinel Node After Neoadjuvancy In Node-Positive Breast Cancer SNB + TAD + Lymphadenectomy - Breast Cancer | Not applicable | Completed | Hospital Clinic of Barcelona | 90 | 2016-06-01 | 2021-04-29 |
| Clinical Performance of a Chlorhexidine Antimicrobial Dressing Chlorhexidine gluconate, Transparent Adhesive Dressing - Catheterization | Phase 2 / Phase 3 | Completed | Solventum US LLC | 68 | 2007-10-01 | 2024-10-24 |
Breast Neoplasms (4) · Pneumonia (1)
Kliniken Essen-Mitte (2) · Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica (1) · Hospital Clinic of Barcelona (1) · Hospital Universitari de Bellvitge (1) · Solventum US LLC (1) · Universitair Ziekenhuis Brussel (1)
Germany (2) · Spain (2) · Belgium (1) · Italy (1)
Immaculada Alonso Vargas, MD PhD (1) · Johannes Holtschmidt, MD (1) · Mark E Rupp, M.D. (1) · Mattea Reinisch, Dr. (1) · Noemi Evangelisti (1) · Sherko Kuemmel, Prof. Dr. (1)